Footnotes
Chapter 1 - Introduction
[1]
House of Representatives, Votes and Proceedings, No. 57, 16 July
2014, p. 709.
[2]
Journals of the Senate, No. 48–28 August 2014, p. 1341.
[3]
See new subsection 54(2AA) which would implement a requirement in the
revised International Standard for Therapeutic Use Exemptions.
[4]
See Standing Committee for Community Affairs website, https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs
[5]
United Nations Educational, Scientific and Cultural Organisation
(UNESCO), International Convention against Doping in Sport, http://www.unesco.org/new/en/social-and-human-sciences/themes/anti-doping/international-convention-against-doping-in-sport/
(accessed 21 October 2014).
[6]
UNESCO, International Convention against Doping in Sport, http://www.unesco.org/new/en/social-and-human-sciences/themes/anti-doping/international-convention-against-doping-in-sport/
(accessed 21 October 2014).
[7]
Explanatory Memorandum (EM), p. 5.
[8]
EM, p. 1.
[9]
EM, p. 2.
[10]
New paragraph 13(1)(fa) of the Bill would provide for the inclusion of
authority in the National Anti-Doping scheme for the ASADA Chief Executive Officer
(CEO) to commence the new prohibited association ADRV by notifying an athlete
or other person that an association with a particular person in a professional
or sports related capacity may be a possible ADRV.
[11]
EM, p. 6.
[12]
See Article 4.4, World Anti-Doping Code (WADA Code), 2015, pp 31–32.
[13]
EM, p. 3.
[14]
EM, p. 3.
[15]
World Anti-Doping Code, International Standard Therapeutic Use
Exemptions, January 2015, Article 5.2.a, p. 12.
[16]
Department of Health, Submission 4, p. 6.
[17]
EM, p. 7.
[18]
EM, p. 4.
[19]
EM, p. 12.
[20]
EM, p. 12.
[21]
See subsection 13(1)(i) of the Australian Sports Anti-Doping Authority
Act 2006 (Act)
[22]
Australian Sports Anti-Doping Authority, Submission 7, p. 4.
[23]
EM, p. 3.
[24]
EM, p. 24.
[25]
EM, p. 11.
[26]
EM, p. 4.
[27]
EM, p. 6.
[28]
EM, p. 2.
[29]
Senate Standing Committee for the Scrutiny of Bills, Alert Digest 10/14,
p. 2.
[30]
To date the PJCHR has not published a response from the Minister.
Chapter 2 - Key issues
[1]
See for example: Mr Simon Hollingsworth, Chief Executive Officer,
Australian Sports Commission, Committee Hansard, 17 October 2014, p. 20.
[2]
The Commercial Bar Association of Victoria (CommBar) submitted that the
Bill should be amended to remove the right of appeal to the Administrative
Appeals Tribunal with regard to a decision by the Australian Sports Drug
Medical Advisory Committee to assert a violation of the anti-doping rules: Submission
8, p. 14.
[3]
Explanatory Memorandum (EM), p. 2. See also Article 2.10, World
Anti-Doping Code (the Code), pp 23–24.
[4]
House of Representatives, Hansard, 16 July 2014, p. 8073.
[5]
See Law Institute of Victoria, Submission 1, p. [2]; Australian
Athletes' Alliance, Submission 6, pp 3–4.
[6]
Submission 8, p. 3.
[7]
Submission 1, p. [2].
[8]
Submission 6, p. 3.
[9]
Submission 6, p. 4.
[10]
Mr Andrew Godkin, First Assistant Secretary, Office for Sport, Committee
Hansard,
17 October 2014, p. 28.
[11]
Mr Godkin, Committee Hansard, p. 28.
[12]
Mr David Learmonth, Deputy Secretary, Committee Hansard, p. 30.
[13]
Mr Godkin, Committee Hansard, p. 33.
[14]
Mr Learmonth, Committee Hansard, p. 33.
[15]
Committee Hansard, p. 31.
[16]
Committee Hansard, p. 32.
[17]
Mr Learmonth, Committee Hansard, p. 32.
[18]
Submission 6, p. 4.
[19]
Tenth Report of the 44th Parliament (Tenth Report), p.
5.
[20]
Submission 6, p. 5.
[21]
Parliamentary Joint Committee on Human Rights (PJCHR), Tenth Report, p. 5.
The PJCHR noted that the statement of compatibility did not provide an
assessment of the compatibility with human rights and sought advice from the
Minister for Sport.
[22]
See for example: Mr Brian Roe, Manager, Ethics and Integrity, Athletics
Australia (AA), Committee Hansard, p. 1; Mr John Coates AC, President, Australian
Olympic Committee (AOC), Committee Hansard, p. 19; CommBar, Submission
8, p. 18.
[23]
Mr Ben McDevitt, Committee Hansard, p. 27.
[24]
EM, p. 23.
[25]
Submission 6, p. 6.
[26]
Submission 8, p. 17.
[27]
See PJCHR, Tenth Report, pp 1-6 and Senate Scrutiny of Bills Committee, Alert
Digest 10/14, p. 2.
[28]
Committee Hansard, p. 28.
[29]
See Article 10.2.1 of the Code.
[30]
See Article 10.2.2 of the Code.
[31]
Committee Hansard, p. 14.
[32]
Mr Brian Roe, Manager, Ethics and Integrity, Committee Hansard, p.
1.
[33]
Committee Hansard, p. 26.
[34]
Mr Roe, Committee Hansard, p. 7.
[35]
Submission 1, p. [2].
[36]
Submission 5, p. 4.
[37]
Committee Hansard, p. 20.
[38]
Committee Hansard, p. 20.
[39]
Committee Hansard, pp 3–4.
[40]
Committee Hansard, pp 3–4.
[41]
Committee Hansard, p. 37.
[42]
Committee Hansard, p. 27 and p. 37.
[43]
Mr Brendan Schwab, General Secretary, Australian Athletes' Alliance, Committee
Hansard,
p. 13.
[44]
Mr Schwab, Committee Hansard, p. 14.
[45]
Mr Schwab, Committee Hansard, p. 14.
[46]
Submission 4, p. 5.
[47]
Committee Hansard, p. 20.
[48]
Submission 2, p. 4.
[49]
See Article 23.2.2 of the Code.
[50]
World Anti-Doping Agency, World Anti-Doping Code 2015 (WADC), p.11.
[51]
Mr Godkin, Committee Hansard, p. 31.
[52]
Mr Godkin, Committee Hansard, p. 31.
[53]
See for example: Exercise and Sports Science Australia, Submission 10;
National LGBTI Health Alliance, Submission 3.
Greens’ Senators Dissenting Report
[1]
Department of Health, Submission 4, p 209.
[2]
Mr Brian Roe, Committee Hansard, 17 October 2014, pp 4-5.
[3]
Mr Terry Nolan QC, Committee Hansard, 17 October 2014, pp 9-10.
[4]
Mr Terry Nolan QC, Committee Hansard, 17 October 2014, p 12.
[5]
Mr Paul Horvath, Committee Hansard, 17 October 2014, p 10.
[6]
Mr Ben McDevitt, Committee Hansard, 17 October 2014, p 31.
[7]
Mr Paul Horvath, Committee Hansard, 17 October 2014, p 7.
[8]
Mr Paul Horvath, Committee Hansard, 17 October 2014, p 7.
[9]
Mr Brendan Schwab, Committee Hansard, 17 October 2014, p 13.
[10]
Australian Athletes’ Alliance, Submission 6, p 111.
[11]
Australian Athletes’ Alliance, Submission 6, p 112.
[12]
Mr Andrew Godkin, Committee Hansard, 17 October 2014, p 29.
[13]
Mr Brendan Schwab, Committee Hansard, 17 October 2014, p 14.
[14]
Mr Ian Prendergast, Committee Hansard, 17 October 2014, p 14.
[15]
Mr Brendan Schwab, Committee Hansard, 17 October 2014, p 17.
[16]
Mr Paul Horvath, Committee Hansard, 17 October 2014, p 7.
[17]
Mr Terry Nolan QC, Committee Hansard, 17 October 2014, p 8.
[18]
Mr Ian Prendergast, Committee Hansard, 17 October 2014, p 14.
[19]
Mr Terry Nolan QC, Committee Hansard, 17 October 2014, p 8.
[20]
Mr Richard Redman, Committee Hansard, 17 October 2014, p 11.
[21]
Mr David Garnsey, Committee Hansard, 17 October 2014, p 16.
[22]
Mr David Garnsey, Committee Hansard, 17 October 2014, p 16.